These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1286 related articles for article (PubMed ID: 17437794)

  • 1. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
    Raman JD; Ng CK; Scherr DS; Margulis V; Lotan Y; Bensalah K; Patard JJ; Kikuchi E; Montorsi F; Zigeuner R; Weizer A; Bolenz C; Koppie TM; Isbarn H; Jeldres C; Kabbani W; Remzi M; Waldert M; Wood CG; Roscigno M; Oya M; Langner C; Wolf JS; Ströbel P; Fernández M; Karakiewcz P; Shariat SF
    Eur Urol; 2010 Jun; 57(6):1072-9. PubMed ID: 19619934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent urothelial cancer after resection of ureteral carcinoma].
    Kong C; Ci J; Liu T
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
    Holmäng S; Lele SM; Johansson SL
    J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
    Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
    BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.